Not Tagged
daiichi sankyo
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'daiichi']
#ash22: new data from the pivotal phase 3 trial of our investigational flt3 inhibitor to be featured in two oral sessions. more info here: #aml #leukemia #cancerresearch 
We create life-changing solutions for patients. See our guidelines: https://t.co/4iEAbpw1Wx